Episode 412: Metformin and the MeMeMe Study: Is It Time? - podcast episode cover

Episode 412: Metformin and the MeMeMe Study: Is It Time?

Feb 11, 202527 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Dr. Kahn is hosting an online Reversing Heart Disease Summit. You can register now at: drtalks.com/summit/reversing-heart-disease

This week, he takes a deep dive into the potential role of metformin as a drug for cancer prevention, diabetes management, and anti-aging, reporting on several new studies, including the MeMeMe randomized trial. The data is compelling.

He also discusses several key topics, including a new study on statins reducing dementia risk, Omega-3’s role in slowing aging, the hidden harms of juicing, microplastics in the brain, menopause and artery health, luteolin for dark hair, and the impact of telemedicine coaching on diabetic heart patients.

For the best experience, listen in Metacast app for iOS or Android